Literature DB >> 3459536

Cyclophosphamide-induced pulmonary toxicity.

D W Siemann, L Macler, D P Penney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3459536      PMCID： PMC2149753     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN： 0306-9443


× No keyword cloud information.
  8 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Repair in mouse lung between multiple small doses of X rays.

Authors:  E L Travis; C S Parkins; J D Down; J F Fowler; H D Thames
Journal:  Radiat Res       Date:  1983-05       Impact factor: 2.841

3.  Early and late pulmonary toxicity in mice evaluated 180 and 420 days following localized lung irradiation.

Authors:  D W Siemann; R P Hill; D P Penney
Journal:  Radiat Res       Date:  1982-02       Impact factor: 2.841

4.  A plethysmographic method for measuring function in locally irradiated mouse lung.

Authors:  E L Travis; B Vojnovic; E E Davies; D G Hirst
Journal:  Br J Radiol       Date:  1979-01       Impact factor: 3.039

5.  Pulmonary toxicity of antineoplastic drugs.

Authors:  G Batist; J L Andrews
Journal:  JAMA       Date:  1981-09-25       Impact factor: 56.272

6.  Effect of cyclophosphamide or x-rays on spontaneously occurring metastases from tumors transplanted into the tails of mice.

Authors:  E L Travis; G Reinartz; A M Chu; J D Down; J F Fowler
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

7.  Vascular permeability and late radiation fibrosis in mouse lung.

Authors:  M P Law
Journal:  Radiat Res       Date:  1985-07       Impact factor: 2.841

8.  Cyclophosphamide-induced lung damage in mice: protection by a small preliminary dose.

Authors:  C H Collis; C M Wilson; J M Jones
Journal:  Br J Cancer       Date:  1980-06       Impact factor: 7.640
  8 in total
  3 in total

Review 1.  Cyclophosphamide toxicity. Characterising and avoiding the problem.

Authors:  L H Fraiser; S Kanekal; J P Kehrer
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

2.  Rare Case of Reversible Pulmonary Arterial Hypertension Secondary to Cyclophosphamide and Doxorubicin Chemotherapy.

Authors:  Aneeqa Javed; Yelizaveta Medina; Amber Bux; Syeda Sahra; Geurys Rojas-Marte
Journal:  Cureus       Date:  2022-06-22

3.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.